IBDEI0FG ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20729,1,1,0)
 ;;=1^206.21
 ;;^UTILITY(U,$J,358.3,20729,1,8,0)
 ;;=8^Subacute Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20729,2)
 ;;=^267548
 ;;^UTILITY(U,$J,358.3,20730,0)
 ;;=206.22^^132^1235^56
 ;;^UTILITY(U,$J,358.3,20730,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20730,1,1,0)
 ;;=1^206.22
 ;;^UTILITY(U,$J,358.3,20730,1,8,0)
 ;;=8^Subacute Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20730,2)
 ;;=^336478
 ;;^UTILITY(U,$J,358.3,20731,0)
 ;;=206.80^^132^1235^41
 ;;^UTILITY(U,$J,358.3,20731,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20731,1,1,0)
 ;;=1^206.80
 ;;^UTILITY(U,$J,358.3,20731,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remission
 ;;^UTILITY(U,$J,358.3,20731,2)
 ;;=^336864
 ;;^UTILITY(U,$J,358.3,20732,0)
 ;;=206.81^^132^1235^40
 ;;^UTILITY(U,$J,358.3,20732,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20732,1,1,0)
 ;;=1^206.81
 ;;^UTILITY(U,$J,358.3,20732,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remiss
 ;;^UTILITY(U,$J,358.3,20732,2)
 ;;=^267551
 ;;^UTILITY(U,$J,358.3,20733,0)
 ;;=206.82^^132^1235^39
 ;;^UTILITY(U,$J,358.3,20733,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20733,1,1,0)
 ;;=1^206.82
 ;;^UTILITY(U,$J,358.3,20733,1,8,0)
 ;;=8^Oth Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20733,2)
 ;;=^336479
 ;;^UTILITY(U,$J,358.3,20734,0)
 ;;=206.90^^132^1235^62
 ;;^UTILITY(U,$J,358.3,20734,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20734,1,1,0)
 ;;=1^206.90
 ;;^UTILITY(U,$J,358.3,20734,1,8,0)
 ;;=8^Unspec Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20734,2)
 ;;=^336865
 ;;^UTILITY(U,$J,358.3,20735,0)
 ;;=206.91^^132^1235^61
 ;;^UTILITY(U,$J,358.3,20735,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20735,1,1,0)
 ;;=1^206.91
 ;;^UTILITY(U,$J,358.3,20735,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Remiss
 ;;^UTILITY(U,$J,358.3,20735,2)
 ;;=^267554
 ;;^UTILITY(U,$J,358.3,20736,0)
 ;;=206.92^^132^1235^60
 ;;^UTILITY(U,$J,358.3,20736,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20736,1,1,0)
 ;;=1^206.92
 ;;^UTILITY(U,$J,358.3,20736,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20736,2)
 ;;=^336480
 ;;^UTILITY(U,$J,358.3,20737,0)
 ;;=207.00^^132^1235^3
 ;;^UTILITY(U,$J,358.3,20737,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20737,1,1,0)
 ;;=1^207.00
 ;;^UTILITY(U,$J,358.3,20737,1,8,0)
 ;;=8^AC Eryth & Erythroleuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20737,2)
 ;;=^336866
 ;;^UTILITY(U,$J,358.3,20738,0)
 ;;=207.01^^132^1235^1
 ;;^UTILITY(U,$J,358.3,20738,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20738,1,1,0)
 ;;=1^207.01
 ;;^UTILITY(U,$J,358.3,20738,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,20738,2)
 ;;=^267556
 ;;^UTILITY(U,$J,358.3,20739,0)
 ;;=207.02^^132^1235^2
 ;;^UTILITY(U,$J,358.3,20739,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20739,1,1,0)
 ;;=1^207.02
 ;;^UTILITY(U,$J,358.3,20739,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,20739,2)
 ;;=^336481
 ;;^UTILITY(U,$J,358.3,20740,0)
 ;;=207.10^^132^1235^9
 ;;^UTILITY(U,$J,358.3,20740,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20740,1,1,0)
 ;;=1^207.10
 ;;^UTILITY(U,$J,358.3,20740,1,8,0)
 ;;=8^Chr Erythremia w/o Remission
 ;;^UTILITY(U,$J,358.3,20740,2)
 ;;=^336867
 ;;^UTILITY(U,$J,358.3,20741,0)
 ;;=207.11^^132^1235^8
 ;;^UTILITY(U,$J,358.3,20741,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20741,1,1,0)
 ;;=1^207.11
 ;;^UTILITY(U,$J,358.3,20741,1,8,0)
 ;;=8^Chr Erythremia in Remission
 ;;^UTILITY(U,$J,358.3,20741,2)
 ;;=^267558
 ;;^UTILITY(U,$J,358.3,20742,0)
 ;;=207.12^^132^1235^7
 ;;^UTILITY(U,$J,358.3,20742,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20742,1,1,0)
 ;;=1^207.12
 ;;^UTILITY(U,$J,358.3,20742,1,8,0)
 ;;=8^Chr Erythremia in Relapse
 ;;^UTILITY(U,$J,358.3,20742,2)
 ;;=^336482
 ;;^UTILITY(U,$J,358.3,20743,0)
 ;;=207.20^^132^1235^28
 ;;^UTILITY(U,$J,358.3,20743,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20743,1,1,0)
 ;;=1^207.20
 ;;^UTILITY(U,$J,358.3,20743,1,8,0)
 ;;=8^Megakaryocytic Leuk w/o Remission
 ;;^UTILITY(U,$J,358.3,20743,2)
 ;;=^336868
 ;;^UTILITY(U,$J,358.3,20744,0)
 ;;=207.21^^132^1235^27
 ;;^UTILITY(U,$J,358.3,20744,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20744,1,1,0)
 ;;=1^207.21
 ;;^UTILITY(U,$J,358.3,20744,1,8,0)
 ;;=8^Megakaryocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,20744,2)
 ;;=^267560
 ;;^UTILITY(U,$J,358.3,20745,0)
 ;;=207.22^^132^1235^26
 ;;^UTILITY(U,$J,358.3,20745,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20745,1,1,0)
 ;;=1^207.22
 ;;^UTILITY(U,$J,358.3,20745,1,8,0)
 ;;=8^Megakaryocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20745,2)
 ;;=^336483
 ;;^UTILITY(U,$J,358.3,20746,0)
 ;;=207.80^^132^1235^47
 ;;^UTILITY(U,$J,358.3,20746,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20746,1,1,0)
 ;;=1^207.80
 ;;^UTILITY(U,$J,358.3,20746,1,8,0)
 ;;=8^Oth Spec Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,20746,2)
 ;;=^336869
 ;;^UTILITY(U,$J,358.3,20747,0)
 ;;=207.81^^132^1235^46
 ;;^UTILITY(U,$J,358.3,20747,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20747,1,1,0)
 ;;=1^207.81
 ;;^UTILITY(U,$J,358.3,20747,1,8,0)
 ;;=8^Oth Spec Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,20747,2)
 ;;=^267562
 ;;^UTILITY(U,$J,358.3,20748,0)
 ;;=207.82^^132^1235^45
 ;;^UTILITY(U,$J,358.3,20748,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20748,1,1,0)
 ;;=1^207.82
 ;;^UTILITY(U,$J,358.3,20748,1,8,0)
 ;;=8^Oth Spec Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,20748,2)
 ;;=^336484
 ;;^UTILITY(U,$J,358.3,20749,0)
 ;;=208.00^^132^1235^21
 ;;^UTILITY(U,$J,358.3,20749,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20749,1,1,0)
 ;;=1^208.00
 ;;^UTILITY(U,$J,358.3,20749,1,8,0)
 ;;=8^Leukemia Unspec w/o Remission
 ;;^UTILITY(U,$J,358.3,20749,2)
 ;;=^336870
 ;;^UTILITY(U,$J,358.3,20750,0)
 ;;=208.01^^132^1235^20
 ;;^UTILITY(U,$J,358.3,20750,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20750,1,1,0)
 ;;=1^208.01
 ;;^UTILITY(U,$J,358.3,20750,1,8,0)
 ;;=8^Leukemia Unspec in Remission
 ;;^UTILITY(U,$J,358.3,20750,2)
 ;;=^267566
 ;;^UTILITY(U,$J,358.3,20751,0)
 ;;=208.02^^132^1235^19
 ;;^UTILITY(U,$J,358.3,20751,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20751,1,1,0)
 ;;=1^208.02
 ;;^UTILITY(U,$J,358.3,20751,1,8,0)
 ;;=8^Leukemia Unspec in Relapse
 ;;^UTILITY(U,$J,358.3,20751,2)
 ;;=^336485
 ;;^UTILITY(U,$J,358.3,20752,0)
 ;;=208.10^^132^1235^12
 ;;^UTILITY(U,$J,358.3,20752,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20752,1,1,0)
 ;;=1^208.10
 ;;^UTILITY(U,$J,358.3,20752,1,8,0)
 ;;=8^Chr Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,20752,2)
 ;;=^336871
 ;;^UTILITY(U,$J,358.3,20753,0)
 ;;=208.11^^132^1235^11
 ;;^UTILITY(U,$J,358.3,20753,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20753,1,1,0)
 ;;=1^208.11
 ;;^UTILITY(U,$J,358.3,20753,1,8,0)
 ;;=8^Chr Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,20753,2)
 ;;=^267569
 ;;^UTILITY(U,$J,358.3,20754,0)
 ;;=208.12^^132^1235^10
 ;;^UTILITY(U,$J,358.3,20754,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20754,1,1,0)
 ;;=1^208.12
 ;;^UTILITY(U,$J,358.3,20754,1,8,0)
 ;;=8^Chr Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,20754,2)
 ;;=^336486
 ;;^UTILITY(U,$J,358.3,20755,0)
 ;;=208.20^^132^1235^53
 ;;^UTILITY(U,$J,358.3,20755,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20755,1,1,0)
 ;;=1^208.20
 ;;^UTILITY(U,$J,358.3,20755,1,8,0)
 ;;=8^Subacute Leukemia w/o Remission
 ;;^UTILITY(U,$J,358.3,20755,2)
 ;;=^336872
 ;;^UTILITY(U,$J,358.3,20756,0)
 ;;=208.21^^132^1235^52
 ;;^UTILITY(U,$J,358.3,20756,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20756,1,1,0)
 ;;=1^208.21
 ;;^UTILITY(U,$J,358.3,20756,1,8,0)
 ;;=8^Subacute Leukemia in Remission
 ;;^UTILITY(U,$J,358.3,20756,2)
 ;;=^267572
 ;;^UTILITY(U,$J,358.3,20757,0)
 ;;=208.22^^132^1235^51
 ;;^UTILITY(U,$J,358.3,20757,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20757,1,1,0)
 ;;=1^208.22
 ;;^UTILITY(U,$J,358.3,20757,1,8,0)
 ;;=8^Subacute Leukemia in Relapse
 ;;^UTILITY(U,$J,358.3,20757,2)
 ;;=^336487
 ;;^UTILITY(U,$J,358.3,20758,0)
 ;;=208.80^^132^1235^38
 ;;^UTILITY(U,$J,358.3,20758,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20758,1,1,0)
 ;;=1^208.80
 ;;^UTILITY(U,$J,358.3,20758,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type w/o Rem
 ;;^UTILITY(U,$J,358.3,20758,2)
 ;;=^336873
 ;;^UTILITY(U,$J,358.3,20759,0)
 ;;=208.81^^132^1235^37
 ;;^UTILITY(U,$J,358.3,20759,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20759,1,1,0)
 ;;=1^208.81
 ;;^UTILITY(U,$J,358.3,20759,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type w/ Rem
 ;;^UTILITY(U,$J,358.3,20759,2)
 ;;=^267574
 ;;^UTILITY(U,$J,358.3,20760,0)
 ;;=208.82^^132^1235^36
 ;;^UTILITY(U,$J,358.3,20760,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20760,1,1,0)
 ;;=1^208.82
 ;;^UTILITY(U,$J,358.3,20760,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type in Relap
 ;;^UTILITY(U,$J,358.3,20760,2)
 ;;=^336488
 ;;^UTILITY(U,$J,358.3,20761,0)
 ;;=209.00^^132^1235^25
 ;;^UTILITY(U,$J,358.3,20761,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20761,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,20761,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Sm Intestine
 ;;^UTILITY(U,$J,358.3,20761,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,20762,0)
 ;;=209.01^^132^1235^22
 ;;^UTILITY(U,$J,358.3,20762,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20762,1,1,0)
 ;;=1^209.01
 ;;^UTILITY(U,$J,358.3,20762,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Duodenum
 ;;^UTILITY(U,$J,358.3,20762,2)
 ;;=^336490
 ;;^UTILITY(U,$J,358.3,20763,0)
 ;;=209.02^^132^1235^24
 ;;^UTILITY(U,$J,358.3,20763,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20763,1,1,0)
 ;;=1^209.02
 ;;^UTILITY(U,$J,358.3,20763,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Jejunum
 ;;^UTILITY(U,$J,358.3,20763,2)
 ;;=^336491
 ;;^UTILITY(U,$J,358.3,20764,0)
 ;;=209.03^^132^1235^23
 ;;^UTILITY(U,$J,358.3,20764,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20764,1,1,0)
 ;;=1^209.03
 ;;^UTILITY(U,$J,358.3,20764,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Ileum
 ;;^UTILITY(U,$J,358.3,20764,2)
 ;;=^336492
 ;;^UTILITY(U,$J,358.3,20765,0)
 ;;=204.00^^132^1236^1
